Master Protocols and Platform Trials: Operational Complexity Against Statistical Efficiency
DOI:
https://doi.org/10.5281/zenodo.22648900Keywords:
Master Protocols and Platform Trials, Translational medicine; Evidence synthesis, Clinical implementation; Health services researchAbstract
Master Protocols and Platform Trials is an area of active development in translational medicine, with evidence that has
accumulated unevenly across its component questions. We review the current evidence base for master protocols and platform
trials, spanning analytical, clinical, implementation, governance, and economic dimensions, focusing on where practice has
converged and where it continues to vary, and set out the practical considerations relevant to a service considering its adoption.
We conclude that selective, context-specific use is best supported by the evidence currently available, rather than uniform
adoption or avoidance.
References
Alvez D, Dumitrescu A, et al. "Master Protocols and Platform Trials: a systematic review". J Transl Med 8(2011): 80-86. DOI: 10.3389/fdgth.2026.1896184
Brankovic K, Kowalczyk B, et al. "Master Protocols and Platform Trials: a methodological appraisal". Clin Pharmacol Ther 10(2014): 91-98. DOI: 10.3390/diagnostics15162117
Castellani R, Ristic C, et al. "Master Protocols and Platform Trials: a multicentre analysis". Nat Rev Drug Discov 12(2017): 102-110. DOI: 10.4103/jrpp.jrpp_20_65
Dumitrescu A, Andric D, et al. "Master Protocols and Platform Trials: a prospective cohort study". Trials 14(2020): 113-122. DOI: 10.3389/fdgth.2026.1763884
Eriksdottir B, Brankovic E, et al. "Master Protocols and Platform Trials: a randomised evaluation". Drug Discov Today 16(2023): 124-134. DOI: 10.2196/48297
Farkas I, Ionescu F, et al. "Master Protocols and Platform Trials: a consensus statement". Clin Cancer Res 18(2011): 135-146. DOI: 10.1007/s00330-025-12031-z
Grabowski P, Petrescu G, et al. "Master Protocols and Platform Trials: a retrospective analysis". BMJ Open 20(2014): 146-158. DOI: 10.3389/fdgth.2026.1699005
Hendriksen W, Wojcik H, et al. "Master Protocols and Platform Trials: a validation study". J Clin Epidemiol 22(2017): 157-170. DOI: 10.3389/fdgth.2026.1834800
Ionescu F, Foscarini I, et al. "Master Protocols and Platform Trials: a scoping review". Contemp Clin Trials 24(2020): 168-182. DOI:
2196/69678 10. Jankowiak G, Grabowski J, et al. "Master Protocols and Platform Trials: a health-economic analysis". Ther Innov Regul Sci 26(2023): 179-185. DOI: 10.7759/cureus.46454
Kowalczyk N, Novotna K, et al. "Master Protocols and Platform Trials: a systematic review". Br J Clin Pharmacol 28(2011): 190-197. DOI: 10.1016/j.ssci.2025.107028
Lindqvist U, Urbanek L, et al. "Master Protocols and Platform Trials: a methodological appraisal". PLoS Med 30(2014): 201-209. DOI: 10.2196/48633
Marchetti D, Doncheva M, et al. "Master Protocols and Platform Trials: a multicentre analysis". Lancet 32(2017): 212-221. DOI: 10.1371/journal.pone.0305949
Novotna E, Eriksdottir N, et al. "Master Protocols and Platform Trials: a prospective cohort study". N Engl J Med 34(2020): 223-233. DOI: 10.1371/journal.pdig.0000514
Ostrowski L, Lindqvist O, et al. "Master Protocols and Platform Trials: a randomised evaluation". JAMA 36(2023): 234-245. DOI: 10.17219/acem/208596
Petrescu S, Szabo P, et al. "Master Protocols and Platform Trials: a consensus statement". Nat Med 38(2011): 245-257. DOI: 10.7759/cureus.104086
Quintero B, Balogh Q, et al. "Master Protocols and Platform Trials: a retrospective analysis". Cell Rep Med 40(2014): 256-269. DOI: 10.1038/s41746-023-00852-5
Ristic C, Castellani R, et al. "Master Protocols and Platform Trials: a validation study". Clin Transl Sci 42(2017): 267-281. DOI: 10.1016/j.mayocpiqo.2022.09.004
Szabo J, Jankowiak S, et al. "Master Protocols and Platform Trials: a scoping review". Pharmacogenomics J 44(2020): 278-284. DOI: 10.1177/08404704241291226
Tarasov Q, Quintero T, et al. "Master Protocols and Platform Trials: a health-economic analysis". Regul Toxicol Pharmacol 46(2023): 289-296. DOI: 10.1093/medlaw/fwad013
Urbanek Z, Zielinski U, et al. "Master Protocols and Platform Trials: a systematic review". Drug Saf 8(2011): 300-308. DOI: 10.2196/89834
Vasquez A, Alvez V, et al. "Master Protocols and Platform Trials: a methodological appraisal". Ann Intern Med 10(2014): 311-320. DOI: 10.1007/s10916-024-02104-9
Wojcik H, Hendriksen W, et al. "Master Protocols and Platform Trials: a multicentre analysis". BMC Med 12(2017): 322-332. DOI: 10.3389/fdgth.2026.1896184
Zielinski O, Ostrowski Z, et al. "Master Protocols and Platform Trials: a prospective cohort study". Sci Transl Med 14(2020): 333-344. DOI: 10.3390/diagnostics15162117
Andric V, Vasquez A, et al. "Master Protocols and Platform Trials: a randomised evaluation". J Transl Med 16(2023): 344-356. DOI: 10.4103/jrpp.jrpp_20_65
Balogh E, Emmerich B, et al. "Master Protocols and Platform Trials: a consensus statement". Clin Pharmacol Ther 18(2011): 355-368. DOI: 10.3389/fdgth.2026.1763884
Chiriac F, Farkas C, et al. "Master Protocols and Platform Trials: a retrospective analysis". Nat Rev Drug Discov 20(2014): 366-380. DOI: 10.2196/48297
Doncheva M, Marchetti D, et al. "Master Protocols and Platform Trials: a validation study". Trials 22(2017): 377-383. DOI: 10.1007/s00330-025-12031-z
Emmerich T, Tarasov E, et al. "Master Protocols and Platform Trials: a scoping review". Drug Discov Today 24(2020): 388-395. DOI: 10.3389/fdgth.2026.1699005
Foscarini C, Chiriac F, et al. "Master Protocols and Platform Trials: a health-economic analysis". Clin Cancer Res 26(2023): 399-407. DOI: 10.3389/fdgth.2026.1834800
Alvez D, Dumitrescu A, et al. "Master Protocols and Platform Trials: a systematic review". BMJ Open 28(2011): 410-419. DOI: 10.2196/69678
Brankovic K, Kowalczyk B, et al. "Master Protocols and Platform Trials: a methodological appraisal". J Clin Epidemiol 30(2014): 421-431. DOI: 10.7759/cureus.46454
Castellani R, Ristic C, et al. "Master Protocols and Platform Trials: a multicentre analysis". Contemp Clin Trials 32(2017): 432-443. DOI: 10.1016/j.ssci.2025.107028
Dumitrescu A, Andric D, et al. "Master Protocols and Platform Trials: a prospective cohort study". Ther Innov Regul Sci 34(2020): 443-455. DOI: 10.2196/48633
Eriksdottir B, Brankovic E, et al. "Master Protocols and Platform Trials: a randomised evaluation". Br J Clin Pharmacol 36(2023): 454-467. DOI: 10.1371/journal.pone.0305949
Farkas I, Ionescu F, et al. "Master Protocols and Platform Trials: a consensus statement". PLoS Med 38(2011): 465-479. DOI: 10.1371/journal.pdig.0000514
Grabowski P, Petrescu G, et al. "Master Protocols and Platform Trials: a retrospective analysis". Lancet 40(2014): 476-482. DOI: 10.17219/acem/208596
Hendriksen W, Wojcik H, et al. "Master Protocols and Platform Trials: a validation study". N Engl J Med 42(2017): 487-494. DOI: 10.7759/cureus.104086
Ionescu F, Foscarini I, et al. "Master Protocols and Platform Trials: a scoping review". JAMA 44(2020): 498-506. DOI: 10.1038/s41746-023-00852-5
Jankowiak G, Grabowski J, et al. "Master Protocols and Platform Trials: a health-economic analysis". Nat Med 46(2023): 509-518. DOI: 10.1016/j.mayocpiqo.2022.09.004
Kowalczyk N, Novotna K, et al. "Master Protocols and Platform Trials: a systematic review". Cell Rep Med 8(2011): 520-530. DOI: 10.1177/08404704241291226
Lindqvist U, Urbanek L, et al. "Master Protocols and Platform Trials: a methodological appraisal". Clin Transl Sci 10(2014): 531-542. DOI: 10.1093/medlaw/fwad013
Marchetti D, Doncheva M, et al. "Master Protocols and Platform Trials: a multicentre analysis". Pharmacogenomics J 12(2017): 542-554. DOI: 10.2196/89834
Novotna E, Eriksdottir N, et al. "Master Protocols and Platform Trials: a prospective cohort study". Regul Toxicol Pharmacol 14(2020): 553-566. DOI: 10.1007/s10916-024-02104-9
Ostrowski L, Lindqvist O, et al. "Master Protocols and Platform Trials: a randomised evaluation". Drug Saf 16(2023): 564-578. DOI: 10.3389/fdgth.2026.1896184
Petrescu S, Szabo P, et al. "Master Protocols and Platform Trials: a consensus statement". Ann Intern Med 18(2011): 575-581. DOI: 10.3390/diagnostics15162117
Quintero B, Balogh Q, et al. "Master Protocols and Platform Trials: a retrospective analysis". BMC Med 20(2014): 586-593. DOI: 10.4103/jrpp.jrpp_20_65
Ristic C, Castellani R, et al. "Master Protocols and Platform Trials: a validation study". Sci Transl Med 22(2017): 597-605. DOI: 10.3389/fdgth.2026.1763884
Szabo J, Jankowiak S, et al. "Master Protocols and Platform Trials: a scoping review". J Transl Med 24(2020): 608-617. DOI: 10.2196/48297
Tarasov Q, Quintero T, et al. "Master Protocols and Platform Trials: a health-economic analysis". Clin Pharmacol Ther 26(2023): 619-629. DOI: 10.1007/s00330-025-12031-z
Urbanek Z, Zielinski U, et al. "Master Protocols and Platform Trials: a systematic review". Nat Rev Drug Discov 28(2011): 630-641. DOI: 10.3389/fdgth.2026.1699005
Vasquez A, Alvez V, et al. "Master Protocols and Platform Trials: a methodological appraisal". Trials 30(2014): 641-653. DOI: 10.3389/fdgth.2026.1834800
Wojcik H, Hendriksen W, et al. "Master Protocols and Platform Trials: a multicentre analysis". Drug Discov Today 32(2017): 652-665. DOI: 10.2196/69678
Zielinski O, Ostrowski Z, et al. "Master Protocols and Platform Trials: a prospective cohort study". Clin Cancer Res 34(2020): 663-677. DOI: 10.7759/cureus.46454
Andric V, Vasquez A, et al. "Master Protocols and Platform Trials: a randomised evaluation". BMJ Open 36(2023): 674-680. DOI: 10.1016/j.ssci.2025.107028
